Navigation Links
Phase III Clinical Studies of Aclidinium Bromide Show Statistical Significance vs. Placebo in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Date:9/2/2008

common symptoms of COPD are breathlessness (or a "need for air"), abnormal sputum (a mix of saliva and mucus in the airway), and a chronic cough. Daily activities, such as walking up a short flight of stairs or carrying a suitcase, can become very difficult as the condition gradually worsens(2). There are significant unmet needs in the treatment of COPD including limited therapeutic options to improve lung function and control exacerbations.

About aclidinium bromide and Genuair(R)

Aclidinium bromide is a novel, long-acting inhaled anticholinergic bronchodilator which has a long residence time at the M3 receptors and a shorter residence time at the M2 receptors. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Forest Laboratories licensed US rights for aclidinium from Almirall, while Almirall maintains rights for the rest of the world. The companies are jointly involved in the development of the compound.

Aclidinium bromide is administered to patients using a novel, state-of-the-art multidose dry powder inhaler (MDPI), Genuair(R). Genuair(R) was designed with an intuitive feedback system, which through a 'coloured control window', an audible click and a slightly sweet taste indicates that the patient has inhaled correctly. The Genuair(R) inhaler contains 30 doses with a visible dose level indicator and also incorporates significant safety features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.

About Forest Laboratories

Forest Laboratories (NYSE: FRX) is a US-based pharmaceutical company with a long track record of building partnerships and developing and delivering products that make a positive difference in people
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... FORT COLLINS, Colo., Dec. 14 Manchester ... 250 mg (chenodiol tablets). On October 22, ... approved Chenodal, an important therapy for patients suffering ... health risk due to disease or advanced age. ... to patients exclusively through Centric Health Resources ("Centric"), ...
(Date:12/14/2009)... INDIANAPOLIS, Dec. 14 Travelers of Interstate 70 ... has become a bit more colorful when 10 multicolored ... which is named going home , will eventually ... Armstrong, a graduate student at Herron School of Art ... and Public Life. ,, Eli Lilly and Company ...
(Date:12/14/2009)... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... the addition of Lt. Gen. Ronald R. Blanck, DO, ... Blanck & Associates, a federal health services consulting firm ... company board now has nine members. ,, Dr. Blanck ... officer and battalion surgeon in Vietnam. He retired 32 ...
Breaking Medicine Technology:Manchester Announces Availability of Chenodal(TM) 2Public Art to Complete Transformation of Key Gateway into Indianapolis 2Public Art to Complete Transformation of Key Gateway into Indianapolis 3Public Art to Complete Transformation of Key Gateway into Indianapolis 4Oxygen Biotherapeutics, Inc. Expands Board of Directors 2Amira Pharmaceuticals to Present at the BIO Investor Forum in San Francisco 60153 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 2Soligenix to Present at 8th Annual BIO Investor Forum 14615 1Soligenix to Present at 8th Annual BIO Investor Forum 14615 2Soligenix to Present at 8th Annual BIO Investor Forum 14615 3Soligenix to Present at 8th Annual BIO Investor Forum 14615 4
(Date:12/14/2009)... Marc Sedwitz Heads up 900-Member Physician Staff , ... ... La Jolla have elected Marc Sedwitz, MD, as the new chief ... as head of the 900-member physician team on Jan. 1, 2010. ... serve as medical staff liaison to Scripps La Jolla’s administrative staff ...
(Date:12/14/2009)... Legislation Critical to Stemming Tide of Tens of ... ,, WASHINGTON, Dec. 14 Legislation approved ... exchange will be crucial in helping to reduce ... occurring each year in the United States, the ... today. The provision was included in the ...
(Date:12/14/2009)... Dec. 14 When Kurth Krause, an ... instructions for landing on the moon, he,was confident ... anything.,Years later, Kurth realized there was one thing ... kidney transplant and even though dialysis machines,would keep ... a transplant. Kurth,wrote: "My wife is 69 and ...
(Date:12/14/2009)... , , MONDAY, Dec. 14 (HealthDay News) -- Here,s good ... a cup or two of java: Coffee and tea ... diabetes. , That,s the conclusion of an Australian ... the lower your risk of diabetes. Every cup of ... the risk of diabetes, the researchers said. , ...
(Date:12/14/2009)... treatments for asthma, COPD, researchers say , , MONDAY, Dec. ... variants that influence lung function, a finding that may ... The international team of researchers compared lung function with ... across the human genome in more than 20,000 people ... five common genetic variants associated with alterations in lung ...
Breaking Medicine News(10 mins):Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 2Health News:New Chief of Staff Takes Over at Scripps Memorial Hospital La Jolla 3Health News:NVHR Applauds Congressional Action to End Federal Ban on Funding Syringe Exchange 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3
... to Health, Care Professionals, Parents and Media About Serious ... ... The Childhood Influenza,Immunization Coalition (CIIC) has launched a Web ... for improved childhood influenza immunization rates in the United,States. The ...
... DC OCTOBER 15, 2007 -- The Cardiovascular ... landmark research study, HORIZONS AMI (Harmonizing Outcomes with ... the nineteenth annual Transcatheter Cardiovascular Therapeutics (TCT) scientific ... to examine the safety and effectiveness of stents ...
... Researchers found that mesalamine use among patients with ... incidence of colorectal cancer when comparing cases and controls. ... Scientific Meeting of the American College of Gastroenterology, researchers ... with ulcerative colitis and Crohns disease to 23 controls ...
... 2007 Using a model to predict reductions ... researchers from Memorial Sloan-Kettering looked at the relative ... pre-cancerous polyps from the colon versus surveillance follow-up ... Winawer, M.D., MACG and colleagues presented their findings ...
... BEIJING, Oct. 15 /Xinhua-PRNewswire-FirstCall/ -- China Medical,Technologies, ... a leading China-based,medical device company that develops, ... and high intensity focused ultrasound ("HIFU"),tumor therapy ... official,approval from the Korean Food and Drug ...
... Facet Solutions, Inc. announced,today that it has ... of,patients to receive its Anatomic Facet Replacement System ... year include a significant,decline in leg and back ... Additionally, the first patient in the,AFRS(TM) study has ...
Other Medicine News:Health News:Childhood Influenza Immunization Coalition Issues New Report to Help Improve Low Childhood Influenza Immunization Rates 2Health News:Childhood Influenza Immunization Coalition Issues New Report to Help Improve Low Childhood Influenza Immunization Rates 3Health News:Childhood Influenza Immunization Coalition Issues New Report to Help Improve Low Childhood Influenza Immunization Rates 4Health News:Childhood Influenza Immunization Coalition Issues New Report to Help Improve Low Childhood Influenza Immunization Rates 5Health News:Horizons AMI trial data to be presented at TCT 2007 2Health News:Mesalamine linked to cancer protection for high risk inflammatory bowel disease patients 2Health News:First colonoscopy with removal of polyps linked to reduction in colon cancer death 2Health News:First colonoscopy with removal of polyps linked to reduction in colon cancer death 3Health News:China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System 2Health News:China Medical Technologies Announces Receipt of Korean FDA Approval for its HIFU System 3Health News:Facet Solution's AFRS(TM) Implant Demonstrates Positive Clinical Results After One Year Follow Up 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: